Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Frontiers in Nuclear Medicine|October 2, 2024
Radiopharmaceutical good practices: Regulation between hospital and industryAlain Faivre-Chauvet, Cécile Bourdeau, Mickaël BourgeoisPharmaceutics|June 28, 2023
Clinical Advances and Perspectives in Targeted Radionuclide TherapyNicolas Lepareur, Barthélémy Ramée, Marie Mougin-Degraef, et al.Orthopaedics & Traumatology, Surgery & Research : OTSR|October 21, 2018
Burnout syndrome in orthopaedic and trauma surgery residents in France: A nationwide surveyGrégoire Faivre, Hugo Kielwasser, Mickaël Bourgeois, et al.Biomed Research International|June 23, 2020
ARRONAX Cyclotron: Setting up of In-House Hospital RadiopharmacyAurelien Vidal, Cécile Bourdeau, Mathieu Frindel, et al.Frontiers in Medicine|October 31, 2022
Immuno-PET: Design options and clinical proof-of-conceptAlexandre Lugat, Clément Bailly, Michel Chérel, et al.Pharmacy (Basel, Switzerland)|April 27, 2026
Clinical Pharmacy in Radiopharmacy: A Cross-Sectional Survey of Practices Within the HUGOPharm NetworkEvan Terrier, Laura Foucault-Fruchard, Nicolas Arlicot, et al.Frontiers in Medicine|September 18, 2015
Focus on the Controversial Aspects of (64)Cu-ATSM in Tumoral Hypoxia Mapping by PET ImagingMathilde Colombié, Sébastien Gouard, Mathieu Frindel, et al.Nuclear Medicine Review. Central & Eastern Europe|January 6, 2012
Contribution of [64Cu]-ATSM PET in molecular imaging of tumour hypoxia compared to classical [18F]-MISO--a selected reviewMickaël Bourgeois, Holisoa Rajerison, François Guerard, et al.Pharmaceutics|April 23, 2022
Circumsporozoite Protein of <i>Plasmodium berghei</i>- and George Baker Virus A-Derived Peptides Trigger Efficient Cell Internalization of Bioconjugates and Functionalized Poly(ethylene glycol)-<i>b</i>-poly(benzyl malate)-Based Nanoparticles in Human Hepatoma CellsElise Vène, Kathleen Jarnouen, Catherine Ribault, et al.Expert Opinion on Biological Therapy|April 26, 2017
Radioimmunoconjugates for treating cancer: recent advances and current opportunitiesMickaël Bourgeois, Clément Bailly, Mathieu Frindel, et al.Pageof 3